home / stock / vtvt / vtvt news

VTVT News and Press, vTv Therapeutics Inc. From 02/28/24

Stock Information
Company Name: vTv Therapeutics Inc.
Stock Symbol: VTVT
Market: NASDAQ
Website: vtvtherapeutics.com
Menu
VTVT VTVT Quote VTVT Short VTVT News VTVT Articles VTVT Message Board
Get VTVT Alerts

News, Short Squeeze, Breakout and More Instantly...
VTVT - US Companies Moving the Markets, Evening edition
Wed, Feb 28, 2024 as of 4:00 pm ET

A look at the top 10 most actives in the United States Marathon Digital Holdings Inc. (MARA) rose 1.8% to $30.87 on volume of 148,760,969 shares Vivani Medical Inc. (VANI) rose 291.9% to $3.9579 on volume of 141,227,838 shares Nikola Corporation (NKLA) rose 2.6% to $0.7758 on volume of 10...
VTVT - vTv Therapeutics Closes $51 Million Private Placement

2024-02-28 11:39:24 ET DENVER, Colo., Feb 28, 2024 ( 247marketnews.com )- Despite announcing that it closed a $51 million private placement, priced at $11.81 per share, vTv Therapeutics Inc. (NASDAQ: VTVT ) was trading slightly higher, but it’s picking up at $14.98, up $6.480...

VTVT - vTv Therapeutics Announces $51 Million Private Placement from Healthcare-focused Institutional Investors and the JDRF T1D Fund

HIGH POINT, N.C., Feb. 28, 2024 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical stage biopharmaceutical company focused on the development of cadisegliatin (TTP399) as an adjunctive therapy to insulin for the treatment of type 1 diabetes ("T1D"), today announced that ...

VTVT - (VTVT) Long Term Investment Analysis

2024-02-26 07:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
VTVT - CANTEX PHARMACEUTICALS TO PARTICIPATE IN THE BIO CEO & INVESTOR CONFERENCE

CANTEX PHARMACEUTICALS TO PARTICIPATE IN THE BIO CEO & INVESTOR CONFERENCE CANTEX PHARMACEUTICALS TO PARTICIPATE IN THE BIO CEO & INVESTOR CONFERENCE PR Newswire WESTON, Fla. , Feb. 22, 2024 /PRNewswire/ -- Cantex Pharmaceuticals , Inc., a clinica...

VTVT - NOVA, BGC and EOSE are among pre market gainers

2024-01-23 08:24:49 ET Rail Vision  ( RVSN ) +29% . TKO Group Holdings  ( TKO ) +19% . vTv Therapeutics  ( VTVT ) +18% . Bit Brother  ( BETS ) +13% . Jeffs Brands  ( JFBR ) +10% . Rumble  ( RUM )...

VTVT - VTVT, HTOO and SOND among mid-day movers

2023-11-29 13:02:14 ET More on mid-day movers stocks. Sonder Holdings Inc. (SOND) Q3 2023 Earnings Call Transcript Fusion Fuel receives purchase order from Portuguese energy company for 1.25 MW electrolyzer facility Fusion Fuel Green receives Nasdaq notice regarding ...
VTVT - MVST, FBIO and VTVT among mid-day movers

2023-11-21 12:43:52 ET Gainers: Safe and Green Development Corp SGD +42% . Anghami ( ANGH ) +42% . Addvantage Technologies Group ( AEY ) +35% . Symbotic SYM +36% . Safety Shot ( SHOT ) +34% . WaveDancer WAVD +23% . Direct Dig...

VTVT - vTv Therapeutics GAAP EPS of -$0.08

2023-11-09 18:03:08 ET More on vTv Therapeutics Financial information for vTv Therapeutics For further details see: vTv Therapeutics GAAP EPS of -$0.08

VTVT - vTv Therapeutics Announces 2023 Third Quarter Financial Results and Provides Corporate Update

HIGH POINT, N.C., Nov. 09, 2023 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical stage biopharmaceutical company focused on the development of cadisegliatin (TTP399) as an adjunctive therapy to insulin for the treatment of type 1 diabetes ("T1D"), today reported financial ...
Previous 10 Next 10